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Abstract. In various ﬁelds of biomedical research, the availability of
electronic data has increased tremendously. Not only is the amount of dis-
ease speciﬁc data increasing, but so is its structural complexity in terms of
dimensionality, multi-modality and inhomogeneity. Consequently, there is
an urgent need for better coordination between bio-medical and computa-
tional researchers in order to make an impact on patient care. In any such
eﬀort, the integration of expert knowledge is essential. A careful synthesis
of good analytical techniques applied to relevant medical questions would
make the analysis both accurate and interpretable and facilitate trans-
disciplinary collaboration. This article summarizes recent challenges and
introduces the contributions to this ESANN special session.
1 Introduction
New technologies in various ﬁelds of biomedical research have led to a dra-
matic increase in the amount and quality of electronic clinical/medical/biological
data. This data is increasingly more accurate, more complex (high-dimensional),
multi-modal and inhomogeneous. Modern electronic genomics health records
consist of high-dimensional vectors and matrices, as well as questionnaire data,
images, text annotations etc. in a variety of formats. The health status and
medical history of the patient is reﬂected in the complex structure of these data
components and their interrelation, see [1–7] for example resources in the context
of genomics data.
More recently [8, 9], there is a shift towards personalized medicine. This is
due to the recognition that complex diseases such as diabetes, heart disease or
cancer, although they have the same phenotype and look symptomatically the
same, have a heterogeneous, patient speciﬁc basis [10]. This patient speciﬁcity
may be due to the patient’s genetic/ethnic background, the presence of speciﬁc
∗The authors thank the Leibniz Center for Informatics – Schloss Dagstuhl for the organi-
zation and support of Seminar 16261 [14], where the idea for this ESANN 2017 special session
was initiated.
mutations as well as the patient’s lifestyle, diet, previous exposure to pathogens,
levels of stress etc. There is now a sense that in some cases, rather than treating
the patient using information gained from statistical analysis of many patients
with the same disease, there is a need for patient speciﬁc strategies. The mantra
is: Do not just treat the disease as a single entity, treat the patient specific version
of the disease. This has led to the need for more reﬁned methods to understand
the causes of each disease.
Machine learning methods are at the center of these eﬀorts [11, 12]. Their
promise is that they will allow a more stratiﬁed analysis of disease and a more
detailed understanding of the reduced set of variables relevant to treatment.
For example, in many cancer centers around the world, there are Personalized
Medicine Initiatives devoted to the treatment of patients who have failed ﬁrst
and second lines of cancer therapy. In such centers, teams of oncologists, sur-
geons, radiologists, geneticists, clinical trial experts, and bioinformaticians meet
and study, e.g., the mutations in recurrent tumors that have caused relapse, us-
ing information from sequencing of patient speciﬁc tumors. Such analyses often
suggest novel therapies and novel methods of treatment, in some cases resulting
in dramatic responses in patients who have failed standard therapies [13].
In this direction, numerous successful machine learning and statistical ap-
proaches have been developed to address speciﬁc tasks using pattern recognition
techniques applied to patient records as well as patient speciﬁc SNP (single
nucleotide polymorphism), gene and protein expression data. However, many
of these approaches neither integrate available expert knowledge systematically
into the underlying mathematical and statistical models, nor do they make use
of expert (prior) knowledge to improve performance and interpretability.
There is now an urgent and well recognized need to develop, investigate, and
apply machine learning and statistical methods for structured biomedical data
analysis, in collaborations which include both experts from knowledge represen-
tation and integration as well as bio-medical and clinical experts who have a
strong interest in developing interpretable models. In other words, the com-
munity needs to create forums for the exchange of ideas among practitioners
in these disciplines, who in their normal life have little or no opportunity for
such dialogues. It is necessary to develop and optimize methods and processing
pipelines which oﬀer eﬃcient solutions for a wide range of bio-medical appli-
cations; i.e. to develop methodologies which allow the systematic incorporation
of domain knowledge into the mathematical approaches used to analyse data.
This would provide an incentive for researchers from both medical and analytical
backgrounds to collaborate and develop interpretable models which may suggest
novel methods of treatment. With these aims in mind, an increasing number of
seminars, conferences, workshops, and dedicated sessions have been organized
in recent years, including [14] and several special sessions at previous ESANN
conferences, e.g. [15–18].
Before summarizing the contributions to the ESANN 2017 special session on
Biomedical data analysis in translational research, we highlight recent develop-
ments and discuss current challenges in the following sections. Obviously, we
cannot provide a complete overview or review all relevant literature in this ﬁeld
of ever-growing relevance.
2 Important concepts and approaches
In biomedical research and practice, structured data sets play a role of increasing
importance, in the form of very complex and inhomogeneous electronic health
records. Their analysis, for instance in the context of decision support systems
in diagnosis and patient monitoring, requires speciﬁc tools for separate modal-
ities of data as well as their integrative treatment in more advanced, uniﬁed
approaches [19–22]. Modern technological platforms for bio-medical data ac-
quisition and measurement generate data with very high spatial or temporal
resolution. Some of these comprise quantities of equal or similar nature in the
diﬀerent dimensions, while in many cases qualitatively disparate features are
collected.
Most modern data sets display high structural complexity or dimensionality,
which in some cases results in thousands to billions of variables. Very frequently,
the number of data dimensions far exceeds the number of samples. These prop-
erties result in fundamentally new challenges for automated data processing.
Expert knowledge about the origin of the data or the relevant biochemical and
bio-medical processes has to be incorporated systematically in order to reduce
complexity, yielding regularization restrictions and techniques speciﬁcally re-
ﬂecting the medical context and/or underlying biological processes [14].
In recent years several approaches have been proposed in the context of
biomedical data analysis. We provide below some examples of the issues and
approaches that seem to be promising, with a few example references as a starting
point for further exploration.
• Biologically motivated sparse coding [30] as present in the visual system
allows for a compact representation of complex data by adaptive, possi-
bly over-complete basis function systems. This leads to low dimensional
representations in functional space, which in turn results in interpretable
models. Adaptation of the models can be guided by general information
theoretical principles, such that natural regularization conditions arise.
For a brief overview of sparse representation techniques in the context of
machine learning and further references see [31, 32].
• Relational and median approaches for data classiﬁcation and clustering
provide valid generalization of vector data analysis in the presence of very
high-dimensional or non-metric data. Like vector based methods, these
approaches oﬀer the possibility to integrate model speciﬁc dissimilarity
concepts in an intuitive way. Examples of speciﬁc methods for relational
or non-vectorial data in various scenarios can be found in [32–36].
• Functional representations of data take into account the functional na-
ture of time series or spectral data and make use of their characteristic
properties such as continuity and diﬀerentiability [37, 38]. In this way, an
inherent regularization is achieved which drastically reduces the number
of free model parameters for a given data set. Corresponding algorithms
and applications are presented in, for instance, [39–41].
• Learning of imbalanced data deals with the complications posed by rare
events, which inﬂuences the sensitivity and accuracy of models. Stan-
dard approaches include over- and undersampling techniques or the use
of class-speciﬁc cost functions [46, 47]. Speciﬁc restrictions due to expert
requirements can be incorporated to meet demand speciﬁcations, e.g. in
terms of the so-called Receiver Operator Characteristics (ROC) [42–44].
In this context, outlier detection, rejection mechanisms and the evaluation
of model conﬁdence and certainty play an important role, see [32,42,45–48]
for examples.
• Interactive data visualization and analysis are addressed in visual ana-
lytics and concern the possibility of employing advanced algorithms for
dimensional reduction and the detection of essential information hidden
in complex data [49]. Low-dimensional projections facilitate direct human
inspection and allow integrating the astonishing cognitive capabilities of
human vision into the processing loop, see [49, 50] for a overviews and
further references.
• Information optimization based methods use the fundamental entropic
principle in nature as the general paradigm for data and information pro-
cessing, taking into account many orders of correlations. Information the-
oretic learning techniques are reviewed in [51], which serves as a source for
further references.
These approaches and paradigms share a number of fundamental principles
of modeling and data analysis. Standard algorithms frequently rely on Euclidean
metrics, which is often either not justiﬁed or costly to compute for complex high-
dimensional data. Alternative dissimilarities, speciﬁcally designed for the data
domain, need to be addressed, such as correlations, divergences for probabilistic
data, structured dissimilarities or pairwise diﬀerences [29,54,55]. Other modeling
methods often rely on a probabilistic treatment and generative models, e.g.
[52,53]. However, density and probability estimation constitute a great challenge
in high dimensional spaces and even more so for non-metric data [11, 49, 51].
Frequently, only a combination of technologies leads to success. Further-
more, it is still an open question how to systematically combine diﬀerent aspects
of the data and which methods to use. This question requires collaboration
among those with expert knowledge and those with knowledge of algorithms
and methods, in each application domain. This knowledge may be integrated as
explicit prior information, but frequently requires human interaction during the
analysis process. The relevant expert knowledge and experience is usually inter-
disciplinary and implicit, which requires dedicated processing of the information.
Here, recommendation schemes and fuzzy decision systems constitute ﬁrst at-
tempts to tackle these problems. The goal of obtaining interpretable models is
closely related to the above mentioned problems [16, 17]. For example, popular
systems like deep multi-layered neural networks [23, 24] or support vector ma-
chines (SVM) [25, 26] do not provide easily accessible information on how the
decision is obtained. Furthermore, the model complexity of the resulting sys-
tems is often huge compared to sparse systems with similar performance. Thus,
conceptual extensions and modiﬁcations of black-box systems are necessary in
order to acquire insight into the underlying decision criteria and to obtain prob-
lem adequate complexity [16, 17]. Other systems, for instance Learning Vector
Quantization and other prototype-based models [27–29, 55], allow for an intu-
itive interpretation of the resulting systems and make use of predeﬁned model
complexity.
3 Relevant research questions and concrete problems
Any systematic attempt to address the problems outlined above requires the
characterization of promising paradigms and methods for expert knowledge inte-
gration in biomedical data information systems. Eﬃcient and reliable processing
pipelines have to be developed in close dialogue with practitioners and domain
experts.
In the following we provide a - certainly incomplete - list of relevant questions
that need to be answered. These questions can be broken down into ﬁve main
areas:
I. Analysis of structured, inhomogeneous and multimodal data
(a) Which general principles, such as information theory, preservation of in-
herent data structures or topological properties oﬀer suitable frameworks
in which to achieve a compact representation of high dimensional data?
How can expert knowledge be integrated systematically in this context?
(b) How can an appropriate level of interpretability of a model be obtained
and objectively assessed in the context of the application domain? How
can the model complexity be chosen adequately to allow for robust and
interpretable results?
(c) Which models are suitable to represent speciﬁc biomedical data, such as
functional or multimodal data adequately? How should models be evalu-
ated and compared?
(d) What are suitable similarity or dissimilarity measures for structured data?
Which families of parameterized measures are available and can be adapted
easily? Can the domain experts’ implicit concepts of similarity be inferred
by interactive systems and incorporated into the models?
II. Feature selection and biomarker detection
(a) How can the inherently non-Euclidean structure of biomedical data be
inferred? Which aspects of particular relevance for the application should
be emphasized? How can these aspects be integrated into a mathematically
consistent description?
(b) How can relevant features or combinations thereof be identiﬁed, which are
speciﬁc to a certain class or cluster of samples, for a particular disease or
behavior? To what extent can domain knowledge be formulated and inte-
grated into the analysis, so as to achieve a semi-guided feature selection?
(c) How can we identify, select, and verify relevant biomarkers in the explo-
ration of high-dimensional and complex data structures? Can systematic
methods for an interactive user-driven selection process be devised?
(d) Are features identiﬁed in diﬀerent model frameworks comparable so that
it is possible to identify their true relevance for the task at hand?
III. Diagnosis and classification
(a) How can we design learning algorithms and classiﬁers, which are robust
with respect to noise, uncertain labels, missing values, or very imbalanced
classes?
(b) How can conﬁdence and certainty of a classiﬁer be estimated reliably? Can
we make use of expert knowledge in the design of reject options or alert
mechanisms?
(c) How can we improve the sensitivity, speciﬁcity of classiﬁers for reliable
diagnosis systems? How can prior knowledge be incorporated to achieve
this goal?
(d) How can several classiﬁers be combined for recommendation or diagnostic
systems? Is it possible to employ redundant information for improvement
of certainty and/or conﬁdence? How can one deal with contradictory or
inconsistent information and classiﬁer decisions?
(e) How can we model temporal aspects of diseases, like stages and disease
progression/regression under treatment?
IV. Generative models of biomedical processes
(a) Can we formulate appropriate evaluation criteria for the reliability of gen-
erative models? Which are stable indicators for model adequacy and ac-
curacy?
(b) How does the interpretability of models interact with their faithfulness and
accuracy in relation to expert knowledge?
(c) How can the modelled processes be presented such that humans can judge
the reliability and quality of the model? How can, in turn, user feedback
be integrated into the models systematically? Can these approaches be
used to reduce the level of uncertainty?
(d) Can generative models contribute to a better understanding of diseases,
disease progression and more general biomedical processes? How does one
simulate adequate scenarios?
V. Visualization and visual analytics
(a) Which visualization techniques are most suitable for heterogeneous and
structured data in the biomedical context? How can we visualize relevant
features in order to facilitate their interpretation by human experts?
(c) How can one design feedback loops that can improve visualization models
by integrating requirements/limitations of domain experts with the model?
(d) How can we eﬀectively visualize patient monitoring and critical events in
a longitudinal assessment of patients?
(e) How can we usefully display the errors/uncertainties resulting e.g. from
embedding high-dimensional data into low dimensional spaces? Can these
be visualized in an intuitive way?
4 Contributions to the ESANN 2017 special session on
Biomedical data analysis in translational research
The three accepted contributions to the special session present a nice cross sec-
tion through the relevant research questions discussed in section 3. The authors
present a prognostic classiﬁcation model for a speciﬁc clinical application, a novel
concept for the analysis of relevance bounds in feature selection, and strategies
for the detection of rare diseases from imbalanced data.
Using data in routine clinical work is not just fallow land waiting for data sci-
entists and computational researchers to come and farm it. A plethora of clinical
scores based on aggregated biomedical measurements and diagnostic interpreta-
tions exist that can inform and compete with novel data analysis methods which
aim to integrate into the clinical routine. The authors of [56] challenge two stan-
dard clinical prognostic scores which are currently in vogue for the prediction
of preterm infant mortality. Not only do they identify additional data support-
ing the performance of standard clinical scores, they also show how to achieve
similar performance using measurement data only. This is important in the
given clinical application as the conventional scores can only be determined by
a labor-intensive procedure which cannot be performed by all caregiving units.
When biomedical data is analysed, identifying a high performance predic-
tive model for outcome or prognosis is often just the ﬁrst step. Frequently, it
is highly desirable to identify the smallest relevant set of biomarkers that can
be used for diagnosis or prognosis in practice. Sometimes, the relevance values
resulting from this analysis also trigger novel clinical research for targeted ther-
apies. Thus, the precise identiﬁcation of relevances is crucial. While strongly
relevant features, which reduce the discriminative power of the classiﬁer when
removed one at a time, are reliably detected by most of the common feature
selection methods, the identiﬁcation of weakly relevant features is challenging.
Weak features often are not relevant on their own but become important when
combined with other features. They also often lack direct indicators of rele-
vance, e.g. high weights in linear classiﬁers. This is often the case for highly
correlated features. The authors of [57] introduce the concepts of the minimum
and maximum linear relevance bounds which provide more information for the
identiﬁcation of strongly and weakly relevant features.
Another important challenge for computational researchers in the biomedical
domain are imbalanced classes. Typically, imbalanced data sets relate to rare
diseases, where only very few patients are known, while healthy controls are
available in abundance. In [58], a number of strategies to circumvent the short-
comings resulting from very imbalanced data sets is studied. Inborn steroido-
genic disorders serve as an example for a relevant diagnostic challenge. Under-
sampling, probably the most commonly used strategy, performed worse than a
baseline given by classiﬁers speciﬁcally designed for missing data but not tai-
lored to imbalanced classes. The considered oversampling strategies outperform
undersampling, but their performance is similar to the baseline results. The
introduction of suitable, speciﬁc costs for the diﬀerent types of misclassiﬁcation
appears to be a most promising strategy. This supports the general claim that
incorporating expert knowledge at the right point can enhance computational
models signiﬁcantly.
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